| Autor: |
Bhaskarabhatla, Ajay, Chatterjee, Chirantan |
| Zdroj: |
Academy of Management Annual Meeting Proceedings; 2013, Vol. 2013 Issue 1, p1-1, 1p |
| Abstrakt: |
The role of the 'high-end' multinational corporations (MNCs) and the 'low-end' bottom-of-the-pyramid (BOP) firms on competition in pharmaceutical markets of the emerging economies remains underexplored. Using an unbalanced panel of monthly price data for 206 narrowly defined therapeutic markets in India spanning 1999-2011, we find that MNC entry induces greater price dispersion and additional MNC entry raises the median price in the market. In contrast, a leading BOP firm's entry-with substantially lower prices compared to MNCs-truncates both the high- and low-ends of the cross-sectional price distribution, and lowers the probability of firm exits from the market. We relate these results to recent theoretical models of mixed-markets featuring high-end and low-end firm entry and highlight how a single low-end firm entry can significantly impact market outcomes in an emerging economy setting. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
